This association was especially strong for MMP-7, with participants in the highest quartile of MMP-7 concentrations having nearly fourfold increased odds of prevalent ILD and a twofold increased risk of incident ILD, typically developing within an average of four years following cohort enrolment. The gene discussed is MMP7; the disease is interstitial lung disease.